Advancing the growth of Georgia's life sciences industry and fostering strategic partnerships to create a healthier world.

At Georgia Bio, we believe that diversity, equity, and inclusion are fundamental to the progress and success of the life sciences industry. Our mission—improving access to innovative technologies and advancing the health and well-being of people worldwide—can only be fully realized when every voice is heard, valued, and respected. We unequivocally denounce all forms of racism, discrimination, and hate. Our organization stands firmly against any actions or words that seek to divide us based on race, ethnicity, religion, gender, or any other identity. These values are non-negotiable and are central to who we are as an organization. As we continue to advocate for the growth of Georgia’s life sciences economy, we are also committed to fostering an environment where diversity thrives, equity is pursued, and inclusion is practiced every day. We recognize that a diverse community of professionals brings a wealth of perspectives and ideas that drive innovation and excellence, which are critically important in healthcare. To reinforce our commitment to these principles, Georgia Bio is taking proactive steps to ensure that our organization not only talks about diversity, equity, and inclusion but lives by these values. These steps include: Diverse Representation: We are committed to ensuring diverse representation across all levels of our organization, including our board, leadership, and membership. Equitable Practices: We will continuously review and improve our policies to ensure they promote equity and fairness for all, particularly in our hiring practices, partnerships, and member services. Inclusive Culture: We are dedicated to creating a culture where everyone feels welcome and respected. We will provide ongoing training and resources to our staff and members to build awareness and skills in areas of diversity, equity, and inclusion. Community Engagement: We will actively engage with underrepresented communities to ensure their voices are included in shaping the future of the life sciences industry. Georgia Bio remains steadfast in its commitment to creating a more just and inclusive society. We understand that this is an ongoing journey, and we are fully dedicated to learning, growing, and taking the necessary actions to uphold our values. We invite our members, partners, and stakeholders to join us in this important work. Together, we can build a life sciences community that truly reflects the diversity of the world we serve.

The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):